Form 4: Director Sells SNX Shares Under 10b5-1 Plan
Insider Transaction Report
TD SYNNEX Director Richard T. Hume exercised stock options and sold 492 shares of common stock on January 30, 2026, under a pre-arranged 10b5-1 trading plan.
Summary
- Richard T. Hume, a Director of TD SYNNEX CORP, executed transactions on January 30, 2026.
- Exercised 492 employee stock options at a price of $107.32 per share.
- Immediately sold 492 shares of common stock at a weighted average price of $160.41 per share.
- The sales price ranged from $160.035 to $160.805.
- These transactions were conducted under a Rule 10b5-1 trading plan adopted on July 14, 2025.
- Following these transactions, Hume beneficially owns 47,515 shares of common stock and 18,365 employee stock options.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a routine insider transaction executed under a pre-arranged plan, which typically carries less market signal than discretionary sales. The profitability of the exercise and sale is a positive for the insider.
Positives
- The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned, non-discretionary sale.
- The sale price of $160.41 per share is significantly higher than the exercise price of $107.32, indicating a profitable transaction for the director.
Negatives
- A director selling shares, even if pre-planned, could be perceived negatively by some investors.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider transactions, particularly those executed under Rule 10b5-1 plans, are common and generally viewed as less indicative of future company performance than open market discretionary trades. These plans allow insiders to sell shares at pre-determined times or prices to avoid accusations of trading on material non-public information.
Stakeholder Impact
- Shareholders: The sale of shares by a director, even if pre-planned, could be interpreted by some as a lack of confidence, though the 10b5-1 plan mitigates this.
Key Dates
| Date | Description |
|---|---|
| 2025-07-14 | Adoption date of Rule 10b5-1 trading plan. |
| 2026-01-30 | Date of stock option exercise and subsequent sale of common stock. |
| 2026-02-02 | Signature date of the Form 4 filing. |
| 2031-10-05 | Expiration date of the employee stock option. |
Recommendation
holdThis Form 4 reports a pre-planned insider transaction (option exercise and sale) by a director. Such routine transactions, especially under a 10b5-1 plan, typically do not signal a change in the company's fundamental outlook or warrant a change in investment recommendation. The transaction is profitable for the insider, but it's a sale, not a purchase, so it doesn't provide a strong bullish signal. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide new information to alter an existing investment thesis.
Keywords
TD SYNNEX, SNX, Form 4, Insider Trading, Stock Option Exercise, Share Sale, Director, 10b5-1 Plan, Richard T. Hume
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.